Induced pluripotent stem cell–derived human platelets: one step closer to the clinic: Figure 1.

Induced pluripotency: history, mechanisms, and applications

(2010) M. Stadtfeld et al.   GENES & DEVELOPMENT

Transient activation ofc-MYCexpression is critical for efficient platelet generation from human induced pluripotent stem cells

(2010) Naoya Takayama et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A requirement for Lim domain binding protein 1 in erythropoiesis

(2010) LiQi Li et al.   JOURNAL OF EXPERIMENTAL MEDICINE

c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development

(2009) C. Niu et al.   BLOOD

c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors

(2009) Y. Guo et al.   BLOOD

Autologous blood cell therapies from pluripotent stem cells

(2009) Claudia Lengerke et al.   BLOOD REVIEWS

Stem cells, pluripotency and nuclear reprogramming

(2009) R. JAENISCH   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells

(2009) Barak Blum et al.   NATURE BIOTECHNOLOGY

Genetic Manipulation of Neural Progenitors Derived from Human Embryonic Stem Cells

(2009) Sujoy K. Dhara et al.   TISSUE ENGINEERING PART A

Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors

(2008) N. Takayama et al.   BLOOD

Distinct Thresholds Govern Myc's Biological Output In Vivo

(2008) Daniel J. Murphy et al.   CANCER CELL